Intech Investment Management LLC Sells 69,255 Shares of UnitedHealth Group Incorporated $UNH

Intech Investment Management LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 25.5% during the first quarter, HoldingsChannel.com reports. The fund owned 201,959 shares of the healthcare conglomerate’s stock after selling 69,255 shares during the quarter. UnitedHealth Group makes up approximately 1.1% of Intech Investment Management LLC’s investment portfolio, making the stock its 11th largest position. Intech Investment Management LLC’s holdings in UnitedHealth Group were worth $105,776,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of UNH. Financial Management Professionals Inc. grew its position in UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock worth $1,165,000 after acquiring an additional 17 shares in the last quarter. Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 28.6% in the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock worth $47,000 after acquiring an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC grew its stake in shares of UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate’s stock valued at $1,080,000 after buying an additional 21 shares during the last quarter. Retirement Planning Group LLC grew its stake in shares of UnitedHealth Group by 5.1% during the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock valued at $225,000 after buying an additional 21 shares during the last quarter. Finally, Net Worth Advisory Group boosted its holdings in shares of UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock valued at $1,907,000 after purchasing an additional 21 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $348.59 on Wednesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a fifty day moving average price of $289.41 and a 200 day moving average price of $371.39. The company has a market cap of $315.71 billion, a P/E ratio of 15.10, a PEG ratio of 2.09 and a beta of 0.45. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 EPS. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s payout ratio is 38.30%.

Analyst Upgrades and Downgrades

UNH has been the subject of several analyst reports. Barclays increased their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Deutsche Bank Aktiengesellschaft cut their price target on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research report on Wednesday, May 14th. Sanford C. Bernstein raised their target price on UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $342.00 to $325.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 20th. Finally, Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $355.77.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.